Biotech Values

[hiddenflem]

Having read more articles in Indian medical journals than I care to think about in recent weeks, I think a lot of it has to do with lack of training in proper study protocols or proper statistical/epidemiologic methods. It amazes me to repeatedly see studies reporting data without using intent-to-treat analysis or reporting on the number of people excluded for poor compliance. As you said though, diabetes is and will be a HUGE problem on the South Asian sub-continent.